Bio Plus Co., Ltd (KOSDAQ:099430)
3,405.00
-75.00 (-2.16%)
Oct 23, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 209.55 billion as of October 23, 2026. It is the 22,209th most valuable company in the world and the 800th biggest in South Korea. Its market cap has decreased by 43.95% in one year.
Market Cap
209.55B
Enterprise Value
267.75B
Revenue
99.15B
Global Rank
Country Rank
#800 South Korea
PE Ratio
21.79
ChartMarket Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 209.55B, a decrease of -53.58%. That is a compound annual growth rate of -14.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 209.55B | -32.31% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WON TECH | 343.66B |
| Samyang Biopharm | 329.04B |
| Curexo | 302.02B |
| ToolGen | 278.51B |
| Value Added Technology | 248.07B |
| Vieworks | 240.94B |
| JETEMA, | 221.86B |
| Sky Labs | 195.12B |